[Clinical trials of a new antirheumatic: remaxeen].
D018501:Antirheumatic Agents; D006801:Humans; D012216:Rheumatic Diseases / Q000628:therapy*; D012457:Salicylamides / Q000627:therapeutic use*
D018501:Antirheumatic Agents; D012457:Salicylamides
RHEUMATISM/therapy; SALICYLAMIDES/therapeutic use
Essais cliniques d'un nouvel antirhumatismal: le remaxeen.